Regulatory P pharmaphorum
FDA won't approve Summit, Akeso's ivonescimab
FDA won't approve Summit, Akeso's ivonescimab Phil.Taylor Sun, 15/11/2026 - 18:23
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Regulatory P pharmaphorum
FDA won't approve Summit, Akeso's ivonescimab Phil.Taylor Sun, 15/11/2026 - 18:23
Software
Ground Truths
Regulatory
STAT Biotech
The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the Chinese drugmaker Akeso.
Agriculture
CropLife
The move reflects the board’s commitment to scaling Bushel’s business and advancing product innovation for an AI-driven future. The post Bushel Names Jim Kaskade CEO, Jake Joraanstad to Chief Product Officer appeared first on CropLife.
Research P Pharmafile
Scottish drug development company PhaSER Biomedical has secured a US$2.7m (£2m), two-year grant renewal from the Gates Foundation to support research into treatments for neglected diseases. The funding continues PhaSER’s participation in the Global Health Discovery Collaboratory,…
Industry P Pharmafile
Executive search firm Coulter Partners has been contracted to assist in the search for a new chief executive for the Cell and Gene Therapy Catapult, to succeed Matthew Durdy. Durdy (pictured), who has been at the helm of the organisation for seven years and worked for CGT Catapul…
Software T The Niche
Last week I wrote about some seemingly encouraging news from uniQure, a firm pursuing a treatment for Huntington’s disease. The FDA had cleared the firm’s BLA. However, I should have given additional background as there’s a more complex backstory here. More on uniQure and HD Ther…
Research
Inside Precision Medicine
A blood biomarker originally developed for Alzheimer’s disease shows promise for detecting advanced chronic traumatic encephalopathy (CTE), potentially paving the way for diagnosis in living patients. The post Blood Biomarker Shows Promise for Detecting Advanced Chronic Traumatic…
Industry
BioCentury
BIOCENTURY | POLITICS, POLICY & LAWBIO’S PLAN FOR ‘SECURING AMERICA’S BIOTECH CENTURY’Biotech trade group trying to use China as a fulcrum to advance policies to enhance U.S. competitiveness
Industry
BioCentury
BIOCENTURY | DEALSCHINA’S INNOVATION MOMENT SEES A RISE IN FIRST IN CLASSScene setter analysis for BioCentury-BayHelix China Healthcare Summit 2026
Regulatory
BioCentury
BIOCENTURY | DATA BYTEEMA’S CHMP BACKS NEW MEDICINES FROM HANSOH, INNOVENT, ASTRAZENECATwo out of three new therapies recommended at committee’s November meeting are from originators in China
Funding
BioCentury
BIOCENTURY | FINANCEWINDWARD PRICES IPO, REZERA POSTPONES ITS OFFERING: FINANCE REPORTPlus: PepGen follows up DM1 data with $125M funding; neuropsychiatric companies Neurosterix, Delix draw nine-figure venture rounds; and more
Industry
GEN
Researchers created a detailed map of the tumor microenvironment surrounding estrogen receptor-positive ductal carcinoma in situ, which may help better predict progression to invasive breast cancer and inform on future therapeutic strategies. The post DCIS Cell Atlas Reveals Clue…
Regulatory B BioPharm International
FDA has reportedly shelved its Commissioner’s National Priority Voucher pilot and paused publishing complete response letters, Zai Lab’s IL-13/IL-31Rα bispecific ZL-1503 shows a 40- to 50-day half-life that points to dosing every 12 weeks, and Wave Life Sciences reports 1-year IN…
Agriculture
CropLife
The New Leader NL7 delivers unmatched efficiency, precision, and power, making fertilizer spreading easier, faster, and more accurate than ever. Cover more acres, reduce waste, and maximize productivity with a spreader built for performance. The post Precision Meets Performance w…
Agriculture
CropLife
Ranco offers NTEP-certified belt scale technology to support legal-for-trade weighing and enhanced material tracking. As an emerging addition to Ranco’s lineup of American-made products, this technology gives fertilizer facilities another tool for improving load-out accuracy, inv…
Agriculture
Global Ag Tech Initiative
Discover how data interoperability is transforming agricultural technology, simplifying regulatory compliance, and enabling smarter decisions across the agricultural value chain. The post Building a Common Language for Agricultural Data appeared first on Global Ag Tech Initiative…
Agriculture
AgriBusiness Global
TFI’s Certified Biostimulant designation validates the water platform chemistry behind the Growthful product line The post Aqueus Receives Biostimulant Certification for Growthful Active Ingredient Tyagra appeared first on AgriBusiness Global.
Industry
GEN
A genomic study reveals how genetic mutations, recombination, and resistance-carrying plasmids shaped the evolution, diversification, and decline of vancomycin-resistant Enterococcus faecium in Danish hospitals between 2012 and 2020. The post How Vancomycin-Resistant <i>Ent…
Industry
BioSpace
Cellectis’ business transformation could cost around 160 global employees their jobs. The company has stopped enrollment in its two CAR T programs as it focuses on trials of its in vivo candidates.
Industry
Pharmaceutical Technology
KOLs interviewed by GlobalData were more optimistic about survodutide’s potential in fatty liver disease (MASLD) than weight loss.
Industry
Inside Precision Medicine
Blocking AEBP1, a protein involved in the formation of scar tissue, prevented the development of severe heart failure in mice following a heart attack. The post Targeting Excessive Scarring Could Prevent Heart Failure Progression appeared first on Inside Precision Medicine.
Software
Inside Precision Medicine
A video recap on how advances in AI, molecular pathology, and liquid biopsy are transforming diagnostics while raising new questions about human expertise and patient care The post AI and the Evolving Fundamentals of Molecular Diagnostics appeared first on Inside Precision Medici…
Industry
Inside Precision Medicine
A new structural map of the AASS enzyme could help researchers develop treatments for glutaric aciduria type 1. Building on promising animal studies, the findings identify molecular mechanisms that could be exploited to prevent harmful metabolite accumulation. The post New Drug T…
Software L Latch Bio
We gave AI models 64 questions spanning viral biology, immunity, and the evidence behind vaccines and treatments.
Industry
MedCity News
Windward Bio’s next-generation antibody drugs for immunology caught the interest of Sanofi, which bought shares in a private placement alongside the biotech’s IPO. Windward’s lead drug candidate addresses the same target as a blockbuster asthma drug from partners Amgen and AstraZ…
Regulatory P Pharmaceutical Executive
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retent…
Manufacturing B BioProcess International
The company continues to make good on its $50 billion commitment to domestic manufacturing.
Software
Inside Precision Medicine
Machine learning models known as PERISCOPE estimate risk of dying after having percutaneous coronary intervention after heart attack better than the established risk score GRACE 2.0. The post AI Model Accurately Predicts Risk for Death After Heart Attack appeared first on Inside…
Clinical
Clinical Trials Arena
Peanut allergy is one of the most common food allergies, with the market having been valued at $6.1bn in 2023. The post Aravax’s peanut allergy drug shows benefit in paediatric patients appeared first on Clinical Trials Arena.
Clinical A Applied Clinical Trials
In this video interview, Shaalan Beg, MD, MBA, FASCO, chief medical officer at ConcertAI, describes how physician awareness and site-level access drive screening inconsistencies, and why acceptance rates are the same across backgrounds once patients are simply asked.
Industry
Pharmaceutical Processing World
By eliminating inefficiencies in design of experiments and bridging lab-to-production gaps, automation helps deliver faster outcomes, driving more therapies to patients. Bringing a new treatment from initial discovery to full commercial manufacturing is a complicated, time-consum…
Regulatory
Drug Delivery Business
Tandem Diabetes Care (Nasdaq: TNDM) has secured an FDA clearance for a tubeless version of its miniaturized automated insulin delivery system. The Tandem Mobi’s new cartridge and infusion set converts the pump into a device that can be worn on the skin for up to a week, beating I…
Manufacturing B BioPharm International
Merck's Dr Dave Maraldo outlines 3 principles for placing manufacturing capacity and how end-to-end ADC supply chains could shift platform thinking.
Software O Omics! Omics!
A reporter recently interviewed about BioNano Genomics (NASDAQ: BNGO), and I reiterated many of the points I made in my piece this summer: great science, very troubled financial outlook. Most glumly, I noted that at their then cash burn rate they had less than two quarters…
Regulatory
MedTech Dive
Intersurgical told customers to immediately stop using affected devices, while Arrow International instructed users to quarantine and return certain products.
Regulatory
MedTech Dive
Intersurgical told customers to immediately stop using affected devices, while Arrow International instructed users to quarantine and return certain products.
Research
Clinical Trials Arena
The post AHA 2026: Tirzepatide Improves Key Biomarkers in Obesity-Related Heart Failure appeared first on Clinical Trials Arena.
Regulatory A Applied Clinical Trials
The agency is still accepting applications but is not reviewing or granting new ones, according to Reuters, while HHS says work under the program is ongoing.
Regulatory
MedTech Dive
CEO Bob White said the endoscope manufacturer accelerated its remediation and quality improvement efforts to “provide the sustained evidence that the agency is expecting.”